Dewpoint Therapeutics, Inc., a biotechnology company pioneering condensate-modulating therapeutics, today announced the ...
BorgWarner's battery management system (BMS) has been selected for an expanded series-production program with a global original equipment manufacturer (OEM). BorgWarner has supplied the BMS to the ...
U.S. FDA Study May Proceed notification enables initiation of clinical trial site activation for the FUNCTION-DMD Phase 1/2 clinical study in patients with Duchenne muscular dystrophy (DMD) – – ...
Make Excel evaluate your data for you.
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in ...
Four years of real-world data from the U.S. EAP demonstrate that arimoclomol was well tolerated and stabilized disease progression in the overall cohort, with changes in clinical severity scores ...
Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...
The Escambia Children's Trust will pay city of Pensacola $1.85 million in TIF contributions for 2021, 2022, 2023, 2024 and ...
Telus Living is planning thousands of rental homes on old network sites across B.C., including Vancouver's Point Grey ...
In one year, fewer than 200 Texas law enforcement agencies have signed more than 250 agreements with the U.S. Immigration and Customs Enforcement 287(g) program to ...